[Analysis of Clinical Characteristics and Prognosis of AML Patients with Co-Mutation of <i>CEBPA</i> Gene and <i>GATA2</i> Gene].
The median age of patients with <i>GATA2</i> gene mutation is lower than that of patients without <i>GATA2</i> gene mutation. <i>GATA2</i> gene mutation further prolongs the survival time of AML patients with <i>CEBPA</i> double mutations and <i>CEBPA-bZIP</i> domain mutation.
Authors
- Yujuan Gao (ORCID: https://orcid.org/0000-0001-8917-2332)
- Yanhua Su (ORCID: https://orcid.org/0000-0002-2265-3390)
- Jia-Yue Sun
- Shanshan Li (ORCID: https://orcid.org/0000-0002-5466-2152)
- Xuewei Yang (ORCID: https://orcid.org/0000-0003-0380-9588)
Institutions
- Harbin Medical University (CN)
- First Affiliated Hospital of Harbin Medical University (CN)
Publication Details
- Journal
- PubMed
- Published
- 2024-10-01
- DOI
- https://doi.org/10.19746/j.cnki.issn.1009-2137.2024.05.002
- Primary Topic
- Acute Myeloid Leukemia Research
- Type
- article